• Home
  • Biography
  • My Reasons
  • Newsletter
  • Contact
  • English English English en
  • Español Español Spanish es
Ignacio Riesgo
  • My Books
  • My Articles
  • My Presentations
  • Serie “10 hot issues”
  • Notes
  • 7 days in healthcare
  • Recommended books
  • Recommended articles
  • Search
  • Menu Menu

3CB6156F-A869-4333-BE57-2F46AED855C1_1_105_c

01/10/2021/by ignacioriesgo

This post is also available in: Spanish

Share this entry
  • Share on Facebook
  • Share on Twitter
  • Share on WhatsApp
  • Share on LinkedIn
  • Share by Mail
0 0 ignacioriesgo ignacioriesgo2021-10-01 09:35:552021-10-01 09:35:553CB6156F-A869-4333-BE57-2F46AED855C1_1_105_c

Últimas entradas

  • Interview with Alan Milburn: “The patient should choose their healthcare; not the one dictated by the State or their doctor”17/04/2026 - 20:21

    “Patients should choose their healthcare; not the one dictated by the state or their doctor.” Alan Milburn, former Health Minister under Tony Blair, answers key questions about the future of  the healthcare system   On April 17, 2026, an interview with Alan Milburn was held at the Redacción Médica offices, focusing on changes in healthcare […]

  • Conversation with Alan Milburn about the “10 Year Health Plan for England”17/04/2026 - 06:52

      On April 17th, 2026, during the Forbes Healthcare Summit 2026, I (Ignacio Riesgo) had the honor of speaking with Alan Milburn about the “10 Year Health Plan for England”, the strategic plan for the renewal of the NHS and healthcare policies in England, published in July 2025 and therefore with almost a year of […]

  • 7 days in healthcare (April 6th-12th, 2026)12/04/2026 - 19:46

      Summary The week’s most impactful health news stories were: Biomedicine: Sir Demis Hassabis, head of Google DeepMind and winner of the 2024 Nobel Prize in Chemistry, wants to automate drug design. Global Health: US-Israeli attacks on Iran have damaged schools and hospitals. International Health Policy: Europe approves only 39% of innovative drugs compared to […]

Tags

Afghanistan (10) Almirall (15) Amazon (9) ASISA (13) AstraZeneca (23) Atrys (15) Bayer (12) Biden (10) Biogen (9) BioNTech (24) CASER (9) China (28) DKV (10) ECDC (13) EMA (10) FDA (16) Grifols (34) GSK (15) HIPRA (28) J&J (8) KKR (10) Lilly (19) long covid (12) Merck (12) Moderna (25) monkeypox (15) MUFACE (17) NHS (12) Novartis (17) Novavax (10) Novo Nordisk (13) Pfizer (41) Quirón (10) Quirónsalud (12) Ribera (18) Roche (17) Rovi (16) Sanitas (23) SANOFI (10) The Lancet (10) Ukraine (9) Viamed (10) Vithas (15) waiting lists (9) WHO (37)
© 2021 Ignacio Riesgo - powered by ADERAL Agencia - powered by Enfold WordPress Theme
Scroll to top
  • English
  • Español